There are many powerful catalysts in the market: SELLAS Life Sciences Group Inc. (SLS) can be one of them

SELLAS Life Sciences Group Inc. (NASDAQ: SLS) closed the day trading at $2.46 up 1.65% from the previous closing price of $2.42. In other words, the price has increased by $+0.0400 from its previous closing price. On the day, 127707 shares were traded. SLS stock price reached its highest trading level at $2.5255 during the session, while it also had its lowest trading level at $2.3900.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.



For a better understanding of SLS, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.40 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3.74. For the most recent quarter (mrq), Quick Ratio is recorded 1.80 and its Current Ratio is at 1.80. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.

On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 02 when Stergiou Angelos M. sold 2,120 shares for $6.25 per share. The transaction valued at 13,252 led to the insider holds 121,167 shares of the business.

Burns John Thomas sold 231 shares of SLS for $1,448 on Dec 02. The VP, Finance & Corp Controller now owns 17,644 shares after completing the transaction at $6.27 per share. On Dec 02, another insider, WOOD BARBARA A, who serves as the EVP, Gen. Counsel, Corp. Sec. of the company, sold 847 shares for $6.25 each. As a result, the insider received 5,298 and left with 42,028 shares of the company.

Valuation Measures:

For the stock, the TTM Price-to-Sale (P/S) ratio is 51.19 while its Price-to-Book (P/B) ratio in mrq is 4.03.

Stock Price History:

Over the past 52 weeks, SLS has reached a high of $7.40, while it has fallen to a 52-week low of $1.77. The 50-Day Moving Average of the stock is 2.9144, while the 200-Day Moving Average is calculated to be 3.4987.

Shares Statistics:

Over the past 3-months, SLS traded about 350.44K shares per day on average, while over the past 10 days, SLS traded about 692.32k shares per day. A total of 20.56M shares are outstanding, with a floating share count of 20.56M. Insiders hold about 0.09% of the company’s shares, while institutions hold 10.60% stake in the company. Shares short for SLS as of Oct 13, 2022 were 821.97k with a Short Ratio of 1.00M, compared to 835.13k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 4.00% and a Short% of Float of 4.00%.

Earnings Estimates

Current recommendations for the stock of the company come from 3 analysts. On average, analysts expect EPS of -$0.39 for the current quarter, with a high estimate of -$0.36 and a low estimate of -$0.42, while EPS last year was -$0.45. The consensus estimate for the next quarter is -$0.35, with high estimates of -$0.28 and low estimates of -$0.41.

Analysts are recommending an EPS of between -$2.13 and -$2.3 for the fiscal current year, implying an average EPS of -$2.19. EPS for the following year is -$1.29, with 3 analysts recommending between -$0.94 and -$1.57.

Revenue Estimates

A total of 3 analysts have provided revenue estimates for SLS’s current fiscal year. The highest revenue estimate was $1M, while the lowest revenue estimate was $1M, resulting in an average revenue estimate of $1M. In the same quarter a year ago, actual revenue was $7.6M, down -86.80% from the average estimate.